|
Index of reports
> Cases with Pain (7)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Intron A (Interferon Alfa-2B) where reactions include pain. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Intron A side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-06-22
Patient: male
Reactions: Nausea, Chills, Pain, Radiation Skin Injury, Pyrexia, Treatment Noncompliance, Rash Pruritic, Fatigue, Lymph Node Pain, Liver Function Test Abnormal, Swelling, Asthenia, Lymphoedema, Post Procedural Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A (Interferon Alfa-2B)
Dosage: 40 miu;;iv, 30 miu,,iv,
Indication: Malignant Melanoma
Start date: 2011-11-17
End date: 2011-12-02
Intron A (Interferon Alfa-2B)
Dosage: 40 miu;;iv, 30 miu,,iv,
Indication: Malignant Melanoma
Start date: 2011-11-07
Intron A
Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
Indication: Malignant Melanoma
Start date: 2012-01-13
End date: 2012-01-25
Intron A
Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
Indication: Malignant Melanoma
Start date: 2012-02-13
Intron A
Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
Indication: Malignant Melanoma
Start date: 2011-12-05
Other drugs received by patient: Levothyroxine Sodium
Possible Intron A side effects in female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-05-23
Patient: female
Reactions: Renal Function Test Abnormal, Food Poisoning, Pain, Chills, Blood Count Abnormal, Headache, Pyrexia, Lower Respiratory Tract Infection, Fatigue, Liver Function Test Abnormal, Feeling of Body Temperature Change, Blood Pressure Abnormal, Blood Creatinine Increased, Lethargy, Blood Test Abnormal, Salmonella Sepsis, Dyspnoea, Cardiac Flutter, Nausea, Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2011-10-06
End date: 2011-12-01
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2012-01-16
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2011-08-29
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2011-10-03
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2011-10-16
Intron A
Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
Indication: Malignant Melanoma
Start date: 2012-05-07
Other drugs received by patient: Micardis; Amlodipine Besylate; Amlodipine Besylate; Atiacid; Zofran; Acetaminophen
Possible Intron A side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-05-17
Patient: male
Reactions: Nausea, Pain, Chills, Pyrexia, Thermal Burn, Rash Pruritic, Hepatic Enzyme Increased, Asthenia, Lymphoedema, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-11-07
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-11-17
End date: 2011-12-02
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-12-05
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2012-02-13
Intron A
Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2012-01-13
End date: 2012-01-25
Other drugs received by patient: Levothyroxine Sodium
Possible Intron A side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-03-02
Patient: male
Reactions: Nausea, Pain, Chills, Radiation Skin Injury, Pyrexia, Thermal Burn, Rash Pruritic, Fatigue, Liver Function Test Abnormal, Asthenia, Post Procedural Infection, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2012-02-13
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-11-07
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2012-01-13
End date: 2012-01-25
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-11-17
End date: 2011-12-02
Intron A
Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
Indication: Malignant Melanoma
Start date: 2011-12-05
Other drugs received by patient: Levothyroxine Sodium
Possible Intron A side effects in 56 year old male
Reported by a physician from Germany on 2012-01-30
Patient: 56 year old male, weighing 102.0 kg (224.4 pounds)
Reactions: Pain, Anaemia Haemolytic Autoimmune, Gastric Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intron A
Possible Intron A side effects in 38 year old male
Reported by a consumer/non-health professional from Spain on 2012-01-11
Patient: 38 year old male
Reactions: Migraine, Economic Problem, Drug Ineffective, Pain, Encephalitis, Liver Disorder, Osteoarthritis, Alopecia, Tendonitis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
Start date: 1996-01-01
Intron A
Dosage: 100000 iu
Indication: Hepatitis C
Start date: 1996-01-01
Possible Intron A side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-04
Patient: female
Reactions: Movement Disorder, Mass, Drug Ineffective, Pain, Operative Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
Start date: 2011-10-22
Ribavirin
Indication: Hepatitis C
Start date: 1999-01-01
Intron A
Indication: Hepatitis C
Start date: 1999-01-01
Intron A
Indication: Hepatitis C
Start date: 2011-10-22
|
